Bio-Techne Corporation's (NASDAQ:TECH) Stock Has Been Sliding …

Aug 5, 2023 · Bio-Techne (NASDAQ:TECH) has had a rough week with its share price down 1.9%. However, stock prices are usually driven...

9%
OFF

Bio-Techne Corporation's (NASDAQ:TECH) Stock Has Been Sliding …

2 weeks from now

Aug 5, 2023 · Bio-Techne (NASDAQ:TECH) has had a rough week with its share price down 1.9%. However, stock prices are usually driven...

yahoo.com

11%
OFF

Bio-Techne Corporation (NASDAQ:TECH) Stock's Been Sliding But ...

2 weeks from now

The formula for return on equityis: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Bio-Techne is: 11% = US$175m ÷ US$1.6b (Based on the trailing twelve months to September 2021). The 'return' is the profit over the last twelve months. One way to conceptualize this is tha...

nasdaq.com

6%
OFF

Declining Stock And Decent Financials: Is The Market Wrong …

2 weeks from now

Jun 20, 2024 · With its stock down 9.6% over the past month, it is easy to disregard Bio-Techne (NASDAQ:TECH). But if you pay close attention, you might find that its key financial indicators …

yahoo.com

5%
OFF

Can Mixed Financials Have A Negative Impact On Bio-Techne …

2 weeks from now

Dec 4, 2024 · Bio-Techne's (NASDAQ:TECH) stock is up by 5.5% over the past three months. However, the company's financials look a bit inconsistent and market outcomes are ultimately …

yahoo.com

9%
OFF

Bio-Techne Corporation's (NASDAQ:TECH) Stock Has Been Sliding …

2 weeks from now

Aug 5, 2023 · Bio-Techne (NASDAQ:TECH) has had a rough week with its share price down 1.9%. However, stock prices are usually driven by a company’s financial performance over the …

statfolio.net

13%
OFF

Bio-Techne Corporation (NASDAQ:TECH) Stock's Been Sliding But …

2 weeks from now

Bio-Techne (NASDAQ:TECH) has had a rough month with its share price down 13%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned …

moomoo.com

9%
OFF

Are Wall Street Analysts Predicting Bio-Techne Stock Will ... - Nasdaq

2 weeks from now

Nov 22, 2024 · Bio-Techne stock prices declined 10.9% in 2024 and gained 8.1% over the past year, lagging behind the S&P 500 Index’s surge of 24.1% on a YTD basis and 30.1% over the …

nasdaq.com

$0.29
OFF

Bio-Techne Co. (NASDAQ:TECH) Given Consensus Rating Of

2 weeks from now

Dec 25, 2024 · Bio-Techne Stock Up 0.4 %. Shares of NASDAQ:TECH traded up $0.29 during trading on Wednesday, hitting $73.03. 309,620 shares of the company were exchanged, …

marketbeat.com

27%
OFF

Bio-techne Stock Price Forecast. Should You Buy TECH?

2 weeks from now

6 days ago · Sell candidate since Jan 06, 2025 Loss -1.27%. The Bio-Techne Corp stock price fell by -2.50% on the last day (Friday, 10th Jan 2025) from $75.19 to $73.31.During the last …

stockinvest.us

4%
OFF

YieldBoost TECH From 0.4% To 17.7% Using Options - Nasdaq

2 weeks from now

19 hours ago · Shareholders of Bio-Techne Corp (Symbol: TECH) looking to boost their income beyond the stock's 0.4% annualized dividend yield can sell the July covered call at the $80 …

nasdaq.com

52%
OFF

Bio-Techne (NASDAQ:TECH) Stock Performs Better Than Its …

2 weeks from now

Sep 19, 2024 · Unfortunately for shareholders, while the Bio-Techne Corporation (NASDAQ:TECH) share price is up 52% in the last five years, that's less than the market …

yahoo.com

1%
OFF

TECH Stock Might Rise From The Expansion Of Designer Protein

2 weeks from now

2 days ago · Bio-Techne has a market capitalization of $11.65 billion. The Zacks Consensus Estimate for the company’s fiscal 2025 earnings indicates a 5.1% year-over-year increase on …

nasdaq.com

$1
OFF

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein …

2 weeks from now

6 days ago · With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has over 3,100 employees worldwide.

nasdaq.com

FAQs about Bio-Techne Corporation's (NASDAQ:TECH) Stock Has Been Sliding … Coupon?

Should you buy Tech Bio-Techne (tech) stock?

TECH Bio-Techne's (NASDAQ:TECH) stock is up by 5.5% over the past three months. However, the company's financials look a bit inconsistent and market outcomes are ultimately driven by long-term fundamentals, meaning that the stock could head in either direction. ...

Could Bio-Techne (Tech) rise in the long-term?

With its stock down 9.6% over the past month, it is easy to disregard Bio-Techne (NASDAQ:TECH). But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. ...

What is the 12-month price forecast for Bio-Techne Corporation (Tech)?

The 12-month stock price forecast is $82.0, which is an increase of 14.72% from the latest price. MINNEAPOLIS , Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan... ...

What's going on with Bio-Techne Corp (Tech) in 2024?

Threats: Intense competition and regulatory hurdles. On November 5, 2024, Bio-Techne Corp (NASDAQ:TECH) filed its 10-Q report, revealing a financial snapshot of the company's performance for the quarter ended September 30, 2024. The filing indicates a slight increase in net sales from $276,935 thousand in 2023 to $289,458 thousand in 2024. ...

Does Bio-Techne have a strong financial position?

Strong Financial Position and Revenue Growth: Despite the challenges, Bio-Techne maintains a strong financial position, with net sales showing growth. The company's ability to increase its sales amidst a competitive landscape is indicative of its operational efficiency and the high demand for its products. ...

Is Bio-Techne a good company to buy?

For instance, the company has a low payout ratio or is being managed efficiently. We then compared Bio-Techne's net income growth with the industry and found that the company's growth figure is lower than the average industry growth rate of 17% in the same 5-year period, which is a bit concerning. ...